ES8802144A1 - Un procedimiento para la preparacion de derivados de fenotiazinas. - Google Patents

Un procedimiento para la preparacion de derivados de fenotiazinas.

Info

Publication number
ES8802144A1
ES8802144A1 ES536525A ES536525A ES8802144A1 ES 8802144 A1 ES8802144 A1 ES 8802144A1 ES 536525 A ES536525 A ES 536525A ES 536525 A ES536525 A ES 536525A ES 8802144 A1 ES8802144 A1 ES 8802144A1
Authority
ES
Spain
Prior art keywords
6alkyl
phenyl
hydrogen
substituted
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES536525A
Other languages
English (en)
Other versions
ES536525A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Frosst Canada and Co
Original Assignee
Merck Frosst Canada and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Frosst Canada and Co filed Critical Merck Frosst Canada and Co
Publication of ES536525A0 publication Critical patent/ES536525A0/es
Publication of ES8802144A1 publication Critical patent/ES8802144A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/38—[b, e]-condensed with two six-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18—[b, e]-condensed with two six-membered rings
    • C07D279/20—[b, e]-condensed with two six-membered rings with hydrogen atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18—[b, e]-condensed with two six-membered rings
    • C07D279/22—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18—[b, e]-condensed with two six-membered rings
    • C07D279/22—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
    • C07D279/30—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom with acyl radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18—[b, e]-condensed with two six-membered rings
    • C07D279/34—[b, e]-condensed with two six-membered rings with hetero atoms directly attached to the ring sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D293/00—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
    • C07D293/10—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

UN PROCEDIMIENTO PARA LA PREPARACION DE DERIVADOS DE FENOTIAZINAS. LAS FENOTIAZINAS (I), DONDE NO EXHAUSTIVAMENTE, R1 ES H O CH3, R2 ES H O 2-OME, R3 ES 4-X CON X F CL O BR, R4 ES H, 7-F O 7-OME, R ES H Y T ES 3-OH; SE PREPARAN POR A) REACCION DE UNA BENZOQUINONA (II) CON UN 2-AMINOBENZOL (III), EN UN DISOLVENTE ADECUADO, TIPO METANOL, EN UN INTERVALO ENTRE C20 Y 60JC, DESPUES B) SE HALOGENA EN PRESENCIA DE UN ACIDO ALCANOICO, COMO EL ACETICO; TRAS LO CUAL C) SE REDUCE, DENTRO DE DISOLVENTE ADECUADO, ENTRE 10 Y 50JC PARA DESPUES; D) HACER REACCIONAR CON ANHIDRIDO, E) CON HALURO DE ALQUILO O ACILO Y FINALMENTE F) HIDROLIZAR CON UNA BASE. COMO INHIBIDORES DE LA BIOSINTESIS DE LEUCOTRIENOS EN MAMIFEROS, SON AGENTES TERAPEUTICOS UTILES EN EL TRATAMIENTO DE LAS CONDICIONES ALERGICAS, ASMA, TRASTORNOS CARDIOVASCULARES E INFLAMACIONES, Y COMO AGENTES CITOPROTECTORES.
ES536525A 1983-10-05 1984-10-04 Un procedimiento para la preparacion de derivados de fenotiazinas. Expired ES8802144A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53934283A 1983-10-05 1983-10-05

Publications (2)

Publication Number Publication Date
ES536525A0 ES536525A0 (es) 1988-04-01
ES8802144A1 true ES8802144A1 (es) 1988-04-01

Family

ID=24150810

Family Applications (1)

Application Number Title Priority Date Filing Date
ES536525A Expired ES8802144A1 (es) 1983-10-05 1984-10-04 Un procedimiento para la preparacion de derivados de fenotiazinas.

Country Status (6)

Country Link
EP (1) EP0138481B1 (es)
JP (1) JPS60155165A (es)
CA (1) CA1272722A (es)
DE (1) DE3484745D1 (es)
DK (1) DK475684A (es)
ES (1) ES8802144A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1309557C (en) 1985-06-18 1992-10-27 Robert N. Young Leukotriene antagonists
DE3526566A1 (de) * 1985-07-25 1987-02-05 Boehringer Mannheim Gmbh N-acyl-dihydroresorufin-derivate, verfahren zu deren herstellung sowie deren verwendung zur bestimmung von wasserstoffperoxid, peroxidatisch wirkender verbindungen oder peroxidase
DE3786030T2 (de) 1986-03-27 1993-12-02 Merck Frosst Canada Inc Tetrahydrocarbazole Ester.
US4803269A (en) * 1986-05-30 1989-02-07 Syntex (U.S.A.) Inc. 4-monosubstituted and 4,6-disubstituted N-(α-phenylethyl)phenoxazines
US4707473A (en) * 1986-05-30 1987-11-17 Syntex (U.S.A.) Inc. 4-monosubstituted and 4,6-disubstituted phenoxazines
EP0480716A1 (en) 1990-10-12 1992-04-15 Merck Frosst Canada Inc. Saturated hydroxyalkylquinoline acids as leukotriene antagonists
US5410054A (en) * 1993-07-20 1995-04-25 Merck Frosst Canada, Inc. Heteroaryl quinolines as inhibitors of leukotriene biosynthesis
US6333322B1 (en) * 1996-03-13 2001-12-25 Eisai Co., Ltd. Nitrogen-containing tricyclic compounds and drugs containing the same
WO1999043683A1 (fr) * 1998-02-27 1999-09-02 Eisai Co., Ltd. Derives de benzothiazine condense heterocyclique
CA2310205A1 (en) * 2000-05-29 2001-11-29 Dalhousie University Unknown
US7232924B2 (en) 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
EP1404324B2 (en) * 2001-06-11 2011-04-06 XenoPort, Inc. Prodrugs of gaba analogs, compositions and uses thereof
WO2005042504A1 (en) 2003-10-31 2005-05-12 Molecular Probes, Inc. Fluorinated resorufin compounds and their application in detecting hydrogen peroxide
CN101068538A (zh) 2004-11-04 2007-11-07 什诺波特有限公司 加巴喷丁前体药物持续释放口服剂型
CN102812083B (zh) * 2010-01-29 2015-04-29 日本瑞翁株式会社 丙烯酸橡胶组合物及橡胶交联物
WO2011093443A1 (ja) * 2010-01-29 2011-08-04 日本ゼオン株式会社 縮合複素環化合物及び組成物
TW201236239A (en) * 2010-11-16 2012-09-01 Solvay Rechargeable metal or metal-ion cell
CN109999041A (zh) 2011-08-02 2019-07-12 亥姆霍兹慕尼黑中心-德国环境健康研究中心(Gmbh) 吩噻嗪衍生物对malt1蛋白酶的选择性抑制
US9868711B2 (en) 2013-03-15 2018-01-16 Bioelectron Technology Corporation Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders
US9296712B2 (en) 2013-03-15 2016-03-29 Edison Pharmaceuticals, Inc. Resorufin derivatives for treatment of oxidative stress disorders
US9670170B2 (en) 2013-03-15 2017-06-06 Bioelectron Technology Corporation Resorufin derivatives for treatment of oxidative stress disorders
CN114213359B (zh) * 2022-01-12 2023-07-25 郑州大学 一种合成1-羟基吩噻嗪类化合物的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58225093A (ja) * 1982-06-25 1983-12-27 Kanegafuchi Chem Ind Co Ltd ベンゾチアジノリフアマイシン誘導体およびその製造法
DE3229122A1 (de) * 1982-08-04 1984-02-09 Bayer Ag, 5090 Leverkusen Anellierte 4h-1,4-benzothiazine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
NZ206795A (en) * 1983-01-21 1987-08-31 Merck Frosst Canada Inc Phenothiazines, analogues and pharmaceutical compositions
EP0136893B1 (en) * 1983-10-05 1989-08-16 Merck Frosst Canada Inc. Benzo[a]phenothiazines and hydro-derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
ES536525A0 (es) 1988-04-01
DK475684A (da) 1985-04-06
DK475684D0 (da) 1984-10-04
EP0138481A3 (en) 1987-04-01
DE3484745D1 (de) 1991-08-01
CA1272722A (en) 1990-08-14
JPS60155165A (ja) 1985-08-15
EP0138481A2 (en) 1985-04-24
EP0138481B1 (en) 1991-06-26

Similar Documents

Publication Publication Date Title
ES8802144A1 (es) Un procedimiento para la preparacion de derivados de fenotiazinas.
OA08182A (fr) Nouveaux dérivés peptidiques à structure polycyclique azotée, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
MX9102734A (es) Derivados de n-acil-2,3-benzodiazepina, procedimiento para su preparacion y composicion farmaceutica que los contiene
DK0787489T3 (da) Sammensætning, der indeholder propionyl-L-carnitin og hydroxycitronsyre eller pantothensyre
KR920018011A (ko) N-아실-α-아미노산 유도체
DK1484059T3 (da) Antivirale sammensætninger, der omfatter phenyleddikesyre derivater
ES8607256A1 (es) Un procedimiento para la preparacion de fenotiazonas halogenadas.
ATE103585T1 (de) Polyamin-derivate als antineoplastische wirkstoffe.
FR2422405A1 (fr) Nouveaux medicaments constitues de derives de l'acide p-aminobenzoique
FR2381776A1 (fr) Procede de preparation de derives d'acide oxazolinoazetidinylbutyrique et nouveaux produits ainsi obtenus
ES8707208A1 (es) Un procedimiento para la preparacion de derivados de benzo(a)fenotiazinas y benzo (a) fenoxazinas.
ES545365A0 (es) Un procedimiento para la preparacion de nuevos aminas terciarias.
FR2623504B1 (fr) Nouveaux derives n-(vinblastinoyl-23) d'acide amino-1 methylphosphonique, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2691149B1 (fr) Nouveaux composes thiochromaniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
IL90179A0 (en) Glutamic acid derivatives,their preparation and pharmaceutical compositions containing them
NZ222261A (en) Pharmaceutical compositions containing antiinflammatory drugs and cyclopentyl ethers
DK416289A (da) Estere af 3-demethylthiocolchicin og n-acylanaloger
EP0149583A3 (fr) 3-Alkoxy-2(N-pyrrolidino)-N-pyridyl-N-furyl (ou thienyl)-methyl-propylamines, leur préparation et les compositions pharmaceutiques les contenant
DE3472257D1 (en) A novel derivative of benzoic acid
AU2742288A (en) Novel compound effective as cerebral insufficiency improver
OA09299A (fr) Nouveaux dérivés N- (vincristinoyl-23) et N- (noranhydro-5' vinblastinoyl-23) d'acide animo-1 méthylphosphonique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
PT86422A (fr) Procede de preparation de derives d:acide dibenzo]be"-oxepine-acetique et de compositions pharmaceutiques les contenant
FR2422618A1 (fr) Derives de bicycloheptane et compositions pharmaceutiques les contenant
FR2422639A1 (fr) Derives d'acide picolinique substitue en 5, procede de preparation et composition anti-hypertensive contenant ces derives
JPS5663955A (en) 1,3-disubstituted pyrrolidine derivative and its preparation